Amalgamated Bank’s Kite Pharma, Inc. KITE Stock Holding History

Amalgamated Bank’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-6,226	Closed	-$1.12M	–	1673
2017 Q3	$1.12M	Buy	6,226 +181	+3%	+$25.2K	0.03%	599
2017 Q2	$627K	Buy	6,045 +914	+18%	+$74.6K	0.02%	852
2017 Q1	$403K	Buy	5,131 +317	+7%	+$19.6K	0.02%	961
2016 Q4	$216K	Buy	4,814 +670	+16%	+$32.9K	0.01%	1351
2016 Q3	$231K	Buy	4,144 +6	+0.1%	+$334	0.01%	1176
2016 Q2	$243K	Buy	+4,138	New	+$203K	0.01%	1147

Amalgamated Bank's KITE Position: Q4 2017 in Review

Amalgamated Bank sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 6,226 shares — an estimated $1.12M sold.

Amalgamated Bank first reported a position in KITE in Q2 2016 and held it in 6 quarters. The position peaked at $1.12M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

Amalgamated Bank reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
Amalgamated Bank sold 6,226 Kite Pharma, Inc. shares in Q4 2017, an estimated $1.12M.
Amalgamated Bank first reported a position in Kite Pharma, Inc. in Q2 2016 and held it in 6 quarters.
Amalgamated Bank's Kite Pharma, Inc. position peaked at $1.12M in Q3 2017.
0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Amalgamated Bank's 13F filing for Q4 2017, filed 13 Feb 2018.